Want to join the conversation?
$HAR 4Q15 Call: In Professional division, despite continued currency headwinds and sluggish growth in Europe and emerging markets, HAR grew revenue both sequentially and YoverY. Company's restructuring plans to improve its European manufacturing footprints are well under way.
$BABA seems to be on a roll! But increasing its yearly sales outlook from 48% to 54% seems over-expectation from the company's part, doesn't it?
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?